Y10S 436/825
Pretreatment for removal of interfering factors from sample
Y10S436/825 (Pretreatment for removal of interfering factors from sample) appears on 456 US grants and 83 published applications in this corpus.
Search patents in Y10S- Granted patents
- 456
- Published applications
- 83
- Assignees
- 241
- Inventors
- 833
- Latest grant
- 11 Sep 2018
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 8 | 0 |
| 1977 | 9 | 0 |
| 1978 | 11 | 0 |
| 1979 | 7 | 0 |
| 1980 | 9 | 0 |
| 1981 | 15 | 0 |
| 1982 | 2 | 0 |
| 1983 | 5 | 0 |
| 1984 | 13 | 0 |
| 1985 | 12 | 0 |
| 1986 | 17 | 0 |
| 1987 | 21 | 0 |
| 1988 | 19 | 0 |
| 1989 | 24 | 0 |
| 1990 | 20 | 0 |
| 1991 | 14 | 0 |
| 1992 | 26 | 0 |
| 1993 | 17 | 0 |
| 1994 | 8 | 0 |
| 1995 | 23 | 0 |
| 1996 | 12 | 0 |
| 1997 | 17 | 0 |
| 1998 | 13 | 0 |
| 1999 | 21 | 0 |
| 2000 | 14 | 0 |
| 2001 | 11 | 5 |
| 2002 | 10 | 10 |
| 2003 | 7 | 11 |
| 2004 | 10 | 9 |
| 2005 | 11 | 11 |
| 2006 | 8 | 4 |
| 2007 | 11 | 9 |
| 2008 | 5 | 3 |
| 2009 | 8 | 4 |
| 2010 | 5 | 6 |
| 2011 | 5 | 1 |
| 2012 | 2 | 3 |
| 2013 | 2 | 2 |
| 2014 | 1 | 3 |
| 2015 | 2 | 1 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Method for altering the binding specificity of plasma proteins by oxidation11 Sep 2018US 10,072,068 B2Redox-Reactive Reagents LLC
- Method of altering the binding specificity of plasma proteins by oxidation-reduction27 Oct 2015US 9,169,317 B2Redox-Reactive Reagents LLC
- TSH immunoassays employing scavenging reagents for cross-reacting endocrine glycoprotein hormone analogues30 Jun 2015US 9,068,994 B2Abbott Point of Care Inc.
- Amelioration of heterophile antibody immunosensor interference9 Sep 2014US 8,828,738 B2Abbott Point of Care Inc.
- TSH immunoassays employing scavenging reagents for cross-reacting endocrine glycoprotein hormone analogues31 Dec 2013US 8,617,826 B2Abbott Point of Care Inc.
- Method for altering the binding specificity of plasma proteins by oxidation18 Feb 2016US 2016/0046695 A1Redox-Reactive Reagents LLC
- Methods of depleting antibodies directed towards major histocompatibility complex17 Sep 2015US 2015/0260622 A1Guy's & St. Thomas' Hospital Nhs Trust ("Gst")
- Methods of depleting antibodies directed towards major histocompatibility complex18 Sep 2014US 2014/0273267 A1Guy's & St. Thomas' Hospital Nhs Trust ("Gst")
- Tsh immunoassays employing scavenging reagents for cross-reacting endocrine glycoprotein hormone analogues13 Mar 2014US 2014/0072989 A1Abbott Point of Care Inc.
- Use of biomarkers for detecting ovarian cancer6 Feb 2014US 2014/0038852 A1The Johns Hopkins University
Most cited
By later US patents
- Reducing interference in ligand-receptor binding assays245US 4,737,456 ASyntex (U.S.A.) Inc. · 1988
- Use of retentate chromatography to generate difference maps229US 6,225,047 B1Ciphergen Biosystems, Inc. · 2001
- Affinity-binding separation and release of one or more selected subset of biological entities from a mixed population thereof173US 5,646,001 AImmunivest Corporation · 1997
- Threshold ligand-receptor assay125US 5,028,535 ABiosite Diagnostics, Inc. · 1991
- Assay method for whole blood samples117US 4,594,327 ASyntex (U.S.A.) Inc. · 1986